$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Nov 28, 2025)
$25.40M
Market Cap
-
P/E Ratio
-6.82
EPS
$10.38
52 Week High
$1.08
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Sonnet Biotherapeutics Holdings Inc. is an innovative biotechnology firm based in Princeton, New Jersey, dedicated to pioneering oncological therapies through its proprietary platform for single-acting and bispecific biologics. The company leverages advanced biotechnological solutions to develop targeted treatments aimed at addressing critical unmet medical needs in cancer care. With a strategic emphasis on next-generation biologics, Sonnet is well-positioned to drive significant advancements in treatment paradigms, ultimately striving to improve patient outcomes in oncology.
LPTX
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
MARA
WULF
NIO
F
MTSR
SOFI
VALE
GOOGL
BTBT
ADTX
DVLT
GRAB
PFE
DNN
IBRX
RIOT
CAN
AG
WBD
APLD
GOOG
IREN
RIG
BAC
AMD
SMR
TMC
PLTR
CDE
ITUB
AGNC
T
AMC
VHAI
NVO
MSTR
NFLX
SAND
MSFT
HBAN
HL
LPTX
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
MARA
WULF
NIO
F
MTSR
SOFI
VALE
GOOGL
BTBT
ADTX
DVLT
GRAB
PFE
DNN
IBRX
RIOT
CAN
AG
WBD
APLD
GOOG
IREN
RIG
BAC
AMD
SMR
TMC
PLTR
CDE
ITUB
AGNC
T
AMC
VHAI
NVO
MSTR
NFLX
SAND
MSFT
HBAN
HL